Biggest Biotech Stocks
- Total Companies
- 725
- Total Market Cap
- 1,259.04B
- Total Revenue
- 253.80B
725 Stocks
No. | Symbol | Company Name | Market Cap | Stock Price | % Change | Revenue |
---|---|---|---|---|---|---|
1 | ABBV | AbbVie Inc. | 273.51B | 154.78 | -0.44% | 56.73B |
2 | AMGN | Amgen Inc. | 131.07B | 245.35 | 0.61% | 26.32B |
3 | GILD | Gilead Sciences, Inc. | 79.25B | 63.18 | 1.51% | 27.47B |
4 | REGN | Regeneron Pharmaceuticals, Inc. | 72.27B | 667.56 | 1.92% | 16.51B |
5 | VRTX | Vertex Pharmaceuticals, Inc. | 66.97B | 261.84 | 3.02% | 7.95B |
6 | MRNA | Moderna, Inc. | 56.59B | 142.28 | 4.42% | 22.60B |
7 | BNTX | BioNTech SE | 38.83B | 159.80 | 5.69% | 25.61B |
8 | BIIB | Biogen Inc. | 29.72B | 202.90 | 2.28% | 10.82B |
9 | SGEN | Seagen, Inc. | 26.98B | 146.55 | 2.81% | 1.67B |
10 | GMAB | Genmab A/S | 19.98B | 30.40 | 3.47% | 1.33B |
11 | ARGX | Argenx SE | 17.29B | 315.91 | 2.27% | 565.09M |
12 | INCY | Incyte Corporation | 16.73B | 75.51 | 1.34% | 3.11B |
13 | ALNY | Alnylam Pharmaceuticals, Inc. | 15.62B | 129.31 | 3.56% | 879.98M |
14 | BGNE | BeiGene Ltd. | 14.69B | 138.58 | 7.28% | 877.04M |
15 | BMRN | BioMarin Pharmaceutical Inc. | 14.64B | 79.12 | 2.33% | 1.88B |
16 | GRFS | Grifols S.A. | 11.89B | 12.92 | -1.67% | 5.61B |
17 | BHVN | Biohaven Pharmaceutical Holding Co. Ltd. | 10.07B | 141.78 | 0.84% | 737.54M |
18 | EXAS | Exact Sciences Corporation | 9.52B | 54.11 | 7.04% | 1.85B |
19 | UTHR | United Therapeutics Corporation | 8.65B | 190.99 | 3.17% | 1.77B |
20 | MRVI | Maravai LifeSciences Holdings, Inc. | 8.25B | 32.33 | 0.12% | 895.32M |
21 | NBIX | Neurocrine Biosciences, Inc. | 8.20B | 85.80 | 1.08% | 1.21B |
22 | EXEL | Exelixis, Inc. | 6.64B | 20.69 | 2.12% | 1.52B |
23 | LEGN | Legend Biotech Corporation | 6.46B | 41.89 | 3.10% | 89.79M |
24 | SRPT | Sarepta Therapeutics, Inc. | 6.24B | 71.30 | 5.58% | 765.79M |
25 | HALO | Halozyme Therapeutics, Inc. | 6.13B | 44.46 | 6.64% | 471.57M |
26 | IONS | Ionis Pharmaceuticals, Inc. | 5.49B | 38.75 | 5.87% | 840.77M |
27 | DNA | Ginkgo Bioworks Holdings, Inc. | 5.32B | 2.74 | 12.76% | 514.69M |
28 | ASND | Ascendis Pharma A/S | 4.96B | 88.97 | 5.00% | 15.23M |
29 | ALKS | Alkermes PLC | 4.85B | 29.69 | 2.63% | 1.20B |
30 | APLS | Apellis Pharmaceuticals, Inc. | 4.49B | 42.16 | 8.55% | 80.94M |
31 | NVAX | Novavax, Inc. | 4.39B | 51.95 | 8.23% | 1.40B |
32 | CRSP | CRISPR Therapeutics AG | 4.21B | 54.36 | 5.47% | 915.36M |
33 | GLPG | Galapagos NV | 3.85B | 57.97 | -1.46% | - |
34 | CERE | Cerevel Therapeutics Holdings, Inc. | 3.85B | 25.97 | 3.06% | - |
35 | RARE | Ultragenyx Pharmaceutical Inc. | 3.80B | 54.35 | -1.65% | 331.95M |
36 | ARWR | Arrowhead Pharmaceuticals, Inc. | 3.78B | 35.77 | 8.79% | 263.42M |
37 | NTLA | Intellia Therapeutics, Inc. | 3.67B | 48.33 | 5.16% | 37.86M |
38 | CYTK | Cytokinetics, Inc. | 3.61B | 42.15 | -2.88% | 65.03M |
39 | NTRA | Natera, Inc. | 3.53B | 36.67 | 8.11% | 667.30M |
40 | BPMC | Blueprint Medicines Corporation | 3.48B | 58.47 | 4.02% | 221.24M |
41 | ZLAB | Zai Lab Limited | 3.48B | 35.35 | 7.32% | 170.93M |
42 | MRTX | Mirati Therapeutics, Inc. | 3.33B | 59.99 | 6.23% | 72.80M |
43 | CVAC | CureVac N.V. | 3.24B | 17.30 | 11.97% | 117.03M |
44 | KRTX | Karuna Therapeutics, Inc. | 3.22B | 107.92 | 3.62% | 36.96M |
45 | ABCM | Abcam PLC | 3.20B | 13.98 | 3.40% | 420.53M |
46 | DNLI | Denali Therapeutics Inc. | 3.09B | 25.12 | 7.95% | 82.88M |
47 | VIR | Vir Biotechnology, Inc. | 3.06B | 23.09 | 3.64% | 2.33B |
48 | DRNA | Dicerna Pharmaceuticals, Inc. | 2.98B | 38.22 | - | 192.85M |
49 | ACAD | ACADIA Pharmaceuticals Inc. | 2.75B | 17.05 | 2.71% | 493.06M |
50 | ROIV | Roivant Sciences Ltd. | 2.63B | 3.80 | 7.65% | 46.06M |
51 | INSM | Insmed, Inc. | 2.57B | 21.50 | 9.14% | 201.35M |
52 | HRMY | Harmony Biosciences Holdings, Inc. | 2.47B | 41.90 | 7.88% | 331.08M |
53 | IOVA | Iovance Biotherapeutics, Inc. | 2.34B | 14.88 | 5.91% | - |
54 | EQRX | EQRx, Inc. | 2.32B | 4.76 | 5.78% | - |
55 | ABCL | AbCellera Biologics Inc. | 2.32B | 8.15 | 4.35% | 489.04M |
56 | FATE | Fate Therapeutics, Inc. | 2.29B | 23.73 | 4.81% | 63.12M |
57 | PTCT | PTC Therapeutics, Inc. | 2.27B | 31.85 | 3.44% | 569.38M |
58 | FOLD | Amicus Therapeutics, Inc. | 2.17B | 7.74 | 3.48% | 317.83M |
59 | OPK | OPKO Health, Inc. | 2.16B | 3.10 | 4.38% | 1.56B |
60 | SAGE | Sage Therapeutics, Inc. | 2.02B | 34.13 | 5.93% | 6.31M |
61 | RLAY | Relay Therapeutics, Inc. | 1.98B | 18.25 | 3.63% | 2.50M |
62 | TWST | Twist Bioscience Corporation | 1.91B | 33.91 | 4.99% | 163.11M |
63 | SWTX | Springworks Therapeutics, Inc. | 1.87B | 37.84 | 1.04% | - |
64 | GBT | Global Blood Therapeutics, Inc. | 1.86B | 28.62 | 3.47% | 210.87M |
65 | MYGN | Myriad Genetics, Inc. | 1.82B | 22.65 | 2.91% | 682.40M |
66 | TPTX | Turning Point Therapeutics, Inc. | 1.79B | 36.09 | 11.12% | 6.05M |
67 | IRWD | Ironwood Pharmaceuticals, Inc. | 1.79B | 11.65 | 1.13% | 422.44M |
68 | KDMN | Kadmon Holdings, Inc. | 1.70B | 9.50 | - | 16.08M |
69 | BCRX | BioCryst Pharmaceuticals, Inc. | 1.65B | 8.90 | 4.71% | 188.03M |
70 | XENE | Xenon Pharmaceuticals Inc. | 1.64B | 30.87 | 3.18% | 22.85M |
71 | TVTX | Travere Therapeutics, Inc. | 1.63B | 25.68 | 9.09% | 228.57M |
72 | AUPH | Aurinia Pharmaceuticals Inc. | 1.62B | 11.45 | 4.19% | 66.32M |
73 | IBRX | ImmunityBio, Inc. | 1.61B | 4.04 | 3.86% | 809.00K |
74 | LGND | Ligand Pharmaceuticals Inc. | 1.53B | 90.99 | 4.91% | 267.68M |
75 | KRYS | Krystal Biotech, Inc. | 1.52B | 59.24 | 4.41% | - |
76 | RCUS | Arcus Biosciences, Inc. | 1.51B | 20.99 | 6.06% | 391.43M |
77 | EBS | Emergent BioSolutions, Inc. | 1.49B | 29.67 | 3.67% | 1.76B |
78 | CCXI | ChemoCentryx, Inc. | 1.49B | 20.91 | 8.91% | 27.33M |
79 | XNCR | Xencor, Inc. | 1.48B | 24.81 | 5.04% | 326.64M |
80 | PCVX | Vaxcyte, Inc. | 1.47B | 25.27 | 2.98% | - |
81 | CLDX | Celldex Therapeutics, Inc. | 1.46B | 31.14 | 6.17% | 4.14M |
82 | VCEL | Vericel Corporation | 1.35B | 28.72 | 3.98% | 157.69M |
83 | ISEE | IVERIC bio, Inc. | 1.35B | 11.60 | 6.81% | - |
84 | CDNA | CareDx, Inc. | 1.35B | 25.29 | 1.49% | 308.41M |
85 | IMCR | Immunocore Holdings plc | 1.34B | 30.46 | 2.22% | 53.58M |
86 | SRRA | Sierra Oncology, Inc. | 1.34B | 54.64 | 0.11% | - |
87 | TNXP | Tonix Pharmaceuticals Holding Corp. | 1.33B | 2.21 | 2,344.69% | - |
88 | PRTA | Prothena Corporation PLC | 1.31B | 27.95 | 7.46% | 201.57M |
89 | RXDX | Prometheus Biosciences, Inc. | 1.26B | 32.05 | 5.60% | 6.29M |
90 | VCYT | Veracyte, Inc. | 1.24B | 17.41 | 5.01% | 250.59M |
91 | ZNTL | Zentalis Pharmaceuticals, Inc. | 1.24B | 26.52 | 8.64% | - |
92 | DVAX | Dynavax Technologies Corporation | 1.23B | 9.73 | -0.92% | 470.10M |
93 | RVMD | Revolution Medicines, Inc. | 1.23B | 16.53 | 6.30% | 26.84M |
94 | AGIO | Agios Pharmaceuticals, Inc. | 1.22B | 22.33 | 0.86% | 832.00K |
95 | MDGL | Madrigal Pharmaceuticals, Inc. | 1.19B | 69.67 | 4.85% | - |
96 | VALN | Valneva SE | 1.17B | 21.67 | 9.44% | 395.55M |
97 | EXAI | Exscientia plc | 1.14B | 9.45 | 6.90% | 36.48M |
98 | CRNX | Crinetics Pharmaceuticals, Inc. | 1.14B | 21.27 | 4.88% | 4.21M |
99 | KROS | Keros Therapeutics, Inc. | 1.11B | 46.14 | 4.70% | 20.10M |
100 | BBIO | BridgeBio Pharma, Inc. | 1.10B | 7.43 | 10.24% | 70.95M |
101 | ALLO | Allogene Therapeutics, Inc. | 1.09B | 7.60 | 7.35% | 205.00K |
102 | RXRX | Recursion Pharmaceuticals, Inc. | 1.05B | 6.11 | 7.76% | 12.95M |
103 | IMAB | I-Mab | 1.05B | 12.70 | 5.92% | 13.75M |
104 | CELU | Celularity, Inc. | 1.04B | 7.56 | 17.76% | 21.34M |
105 | ENTA | Enanta Pharmaceuticals, Inc. | 1.02B | 49.03 | 0.53% | 91.56M |
106 | ARQT | Arcutis Biotherapeutics, Inc. | 1.00B | 19.53 | 7.01% | - |
107 | MYOV | Myovant Sciences Ltd. | 997.17M | 10.46 | 5.66% | 230.97M |
108 | LYEL | Lyell Immunopharma, Inc. | 991.92M | 4.03 | 3.07% | 8.76M |
109 | TGTX | TG Therapeutics, Inc. | 985.05M | 6.82 | 5.41% | 7.91M |
110 | TIL | Instil Bio, Inc. | 965.00M | 7.47 | 8.73% | - |
111 | GRNA | GreenLight Biosciences Holdings, PBC | 961.33M | 7.09 | -0.56% | 1.60M |
112 | SANA | Sana Biotechnology, Inc. | 957.82M | 5.05 | 3.06% | - |
113 | BLU | BELLUS Health Inc. | 939.38M | 8.80 | 2.92% | 9.52K |
114 | MORF | Morphic Holding, Inc. | 938.75M | 24.53 | 3.33% | 18.91M |
115 | RGNX | REGENXBIO Inc. | 936.01M | 21.70 | 4.98% | 473.68M |
116 | NUVB | Nuvation Bio, Inc. | 931.41M | 4.27 | 5.43% | - |
117 | KYMR | Kymera Therapeutics, Inc. | 901.55M | 17.43 | 5.06% | - |
118 | NVTA | Invitae Corporation | 871.30M | 3.80 | 1.88% | 480.52M |
119 | IMGN | ImmunoGen, Inc. | 871.12M | 3.95 | 3.40% | 92.23M |
120 | FGEN | FibroGen, Inc. | 858.34M | 9.20 | -0.43% | 257.71M |
121 | VTYX | Ventyx Biosciences, Inc. | 855.26M | 16.80 | 13.13% | - |
122 | MNKD | MannKind Corporation | 848.62M | 3.36 | 9.80% | 70.00M |
123 | KURA | Kura Oncology, Inc. | 830.29M | 12.46 | 7.51% | - |
124 | SNDX | Syndax Pharmaceuticals, Inc. | 822.68M | 14.63 | 4.35% | 139.33M |
125 | EDIT | Editas Medicine, Inc. | 798.30M | 11.63 | 4.40% | 25.82M |
126 | CINC | CinCor Pharma, Inc. | 786.63M | 20.86 | -6.37% | - |
127 | MIRM | Mirum Pharmaceuticals, Inc. | 764.69M | 24.02 | - | 32.03M |
128 | ORGO | Organogenesis Holdings, Inc. | 764.45M | 5.92 | 2.25% | 463.62M |
129 | CDMO | Avid Bioservices, Inc. | 761.93M | 12.34 | 4.14% | 115.98M |
130 | KDNY | Chinook Therapeutics, Inc. | 758.69M | 13.75 | - | 53.97M |
131 | DCPH | Deciphera Pharmaceuticals, Inc. | 756.85M | 11.43 | 7.63% | 100.22M |
132 | ERAS | Erasca, Inc. | 751.86M | 6.17 | 3.01% | - |
133 | ALEC | Alector, Inc. | 750.00M | 9.11 | 5.56% | 227.45M |
134 | RNA | Avidity Biosciences, Inc. | 743.47M | 14.94 | 9.85% | 8.42M |
135 | NWBO | Northwest Biotherapeutics, Inc. | 743.39M | 0.65 | -6.74% | 1.17M |
136 | CPRX | Catalyst Pharmaceuticals, Inc. | 736.93M | 7.17 | 2.43% | 153.72M |
137 | IGMS | IGM Biosciences, Inc. | 734.01M | 17.26 | 14.23% | - |
138 | REPL | Replimune Group, Inc. | 731.28M | 15.49 | 6.61% | - |
139 | AVXL | Anavex Life Sciences Corp. | 729.97M | 9.43 | 8.14% | - |
140 | RCKT | Rocket Pharmaceuticals, Inc. | 709.73M | 10.78 | 18.99% | - |
141 | MRUS | Merus N.V. | 709.00M | 16.28 | 1.88% | 52.41M |
142 | VERV | Verve Therapeutics, Inc. | 693.42M | 14.25 | 3.34% | - |
143 | DSGN | Design Therapeutics, Inc. | 681.10M | 12.21 | 2.52% | - |
144 | MOR | MorphoSys AG | 676.15M | 4.95 | 4.87% | 179.61M |
145 | ITOS | iTeos Therapeutics, Inc. | 675.63M | 19.01 | 3.88% | 497.30M |
146 | DICE | DICE Therapeutics, Inc. | 671.81M | 17.57 | 4.58% | 1.13M |
147 | NKTX | Nkarta, Inc. | 668.46M | 13.81 | -0.36% | - |
148 | GOSS | Gossamer Bio, Inc. | 666.29M | 8.64 | 2.37% | - |
149 | ATAI | ATAI Life Sciences N.V. | 662.22M | 4.12 | 1.98% | 20.38M |
150 | PRTC | PureTech Health PLC | 661.80M | 23.00 | 6.48% | 17.39M |
151 | QURE | uniQure N.V. | 660.06M | 14.15 | 2.39% | 525.34M |
152 | AMRN | Amarin Corporation Plc | 659.03M | 1.66 | 10.67% | 535.65M |
153 | PMVP | PMV Pharmaceuticals, Inc. | 647.15M | 14.20 | 12.25% | - |
154 | RANI | Rani Therapeutics Holdings, Inc. | 635.97M | 11.50 | 5.60% | 2.72M |
155 | STOK | Stoke Therapeutics, Inc. | 619.98M | 15.82 | -0.50% | 3.00M |
156 | CHRS | Coherus BioSciences, Inc. | 612.42M | 7.91 | 4.08% | 303.63M |
157 | SRNE | Sorrento Therapeutics, Inc. | 610.65M | 1.57 | 9.03% | 57.03M |
158 | KNSA | Kiniksa Pharmaceuticals Ltd. | 602.70M | 8.70 | 4.19% | 70.73M |
159 | SGMO | Sangamo Therapeutics, Inc. | 600.32M | 3.95 | 1.80% | 112.65M |
160 | EGRX | Eagle Pharmaceuticals, Inc. | 597.72M | 47.07 | 4.21% | 246.17M |
161 | ANAB | AnaptysBio, Inc. | 588.81M | 20.89 | -0.38% | 52.90M |
162 | CRBU | Caribou Biosciences, Inc. | 587.02M | 9.67 | -0.72% | 10.68M |
163 | PHVS | Pharvaris, N.V | 581.82M | 17.55 | 2.58% | - |
164 | SLN | Silence Therapeutics PLC | 581.40M | 9.67 | -4.07% | 12.42M |
165 | GHRS | GH Research PLC | 578.47M | 11.12 | 9.56% | - |
166 | VNDA | Vanda Pharmaceuticals Inc. | 565.46M | 10.01 | 1.83% | 266.21M |
167 | VAXX | Vaxxinity, Inc. | 563.20M | 4.47 | 0.45% | 66.00K |
168 | ICPT | Intercept Pharmaceuticals, Inc. | 559.20M | 18.82 | 3.69% | 370.39M |
169 | INBX | Inhibrx, Inc. | 557.84M | 14.29 | 4.08% | 7.27M |
170 | IMGO | Imago BioSciences, Inc. | 545.14M | 16.16 | 6.88% | - |
171 | BCYC | Bicycle Therapeutics PLC | 541.97M | 18.28 | 6.90% | 13.75M |
172 | PNT | POINT Biopharma Global, Inc. | 539.84M | 5.99 | 6.58% | - |
173 | CGEM | Cullinan Oncology, Inc. | 539.63M | 12.05 | 10.75% | 18.94M |
174 | GERN | Geron Corporation | 535.97M | 1.42 | 0.71% | 1.38M |
175 | IPSC | Century Therapeutics, Inc. | 534.19M | 9.08 | 2.48% | - |
176 | DAWN | Day One Biopharmaceuticals, Inc. | 532.17M | 8.59 | 9.43% | - |
177 | CSTL | Castle Biosciences, Inc. | 528.63M | 20.13 | 3.34% | 98.12M |
178 | AFMD | Affimed N.V. | 524.11M | 3.51 | 7.01% | 45.87M |
179 | HLVX | HilleVax, Inc. | 523.14M | 15.65 | 7.86% | - |
180 | ATRA | Atara Biotherapeutics, Inc. | 522.14M | 5.59 | 5.47% | 24.10M |
181 | QSI | Quantum-Si Incorporated | 519.72M | 3.74 | 8.09% | - |
182 | CNTA | Centessa Pharmaceuticals PLC | 518.06M | 5.51 | 6.78% | - |
183 | AMLX | Amylyx Pharmaceuticals, Inc. | 513.92M | 8.78 | 5.40% | 285.00K |
184 | PHAR | Pharming Group N.V. | 509.92M | 7.86 | -3.68% | 221.89M |
185 | FHTX | Foghorn Therapeutics, Inc. | 506.74M | 12.22 | 8.43% | 4.95M |
186 | AURA | Aura Biosciences, Inc. | 498.88M | 17.05 | 4.47% | - |
187 | PRAX | Praxis Precision Medicines, Inc. | 498.35M | 10.95 | 0.28% | - |
188 | ZEAL | Zealand Pharma A/S | 496.51M | 11.49 | 14.32% | 44.33M |
189 | TNGX | Tango Therapeutics, Inc. | 494.86M | 5.63 | 10.83% | 36.41M |
190 | NAUT | Nautilus Biotechnology, Inc. | 491.62M | 3.95 | 3.95% | - |
191 | HUMA | Humacyte, Inc. | 487.21M | 4.73 | 3.73% | 1.34M |
192 | TSVT | 2seventy bio, Inc. | 484.58M | 12.88 | 7.60% | 51.05M |
193 | ARCT | Arcturus Therapeutics Holdings Inc. | 483.20M | 18.29 | 8.61% | 15.48M |
194 | IMVT | Immunovant, Inc. | 479.60M | 4.10 | 1.99% | - |
195 | CTIC | CTI BioPharma Corp. | 479.45M | 4.40 | -2.22% | 2.30M |
196 | OCGN | Ocugen, Inc. | 478.77M | 2.22 | 10.45% | - |
197 | VERA | Vera Therapeutics, Inc. | 478.29M | 17.68 | 11.69% | - |
198 | MESO | Mesoblast Limited | 477.43M | 3.67 | 1.66% | 9.89M |
199 | NRIX | Nurix Therapeutics, Inc. | 469.73M | 10.45 | 7.73% | 34.36M |
200 | KNTE | Kinnate Biopharma, Inc. | 458.69M | 10.43 | 3.27% | - |
201 | INO | Inovio Pharmaceuticals, Inc. | 455.79M | 1.99 | 5.29% | 1.60M |
202 | KPTI | Karyopharm Therapeutics, Inc. | 453.48M | 5.71 | 4.58% | 234.23M |
203 | YMAB | Y-mAbs Therapeutics, Inc. | 449.86M | 10.29 | 5.22% | 40.00M |
204 | ALBO | Albireo Pharma, Inc. | 447.88M | 22.89 | -18.37% | 45.45M |
205 | AGEN | Agenus Inc. | 447.14M | 1.65 | 4.43% | 309.89M |
206 | MDXG | MiMedx Group, Inc. | 446.61M | 3.94 | 3.14% | 257.54M |
207 | JANX | Janux Therapeutics, Inc. | 445.85M | 10.71 | 2.88% | 4.85M |
208 | IDYA | IDEAYA Biosciences, Inc. | 441.65M | 11.43 | 9.59% | 32.05M |
209 | RAPT | Rapt Therapeutics, Inc. | 440.81M | 14.87 | 8.15% | 3.23M |
210 | VXRT | Vaxart, Inc. | 427.39M | 3.38 | 7.99% | 471.00K |
211 | DRTS | Alpha Tau Medical Ltd. | 425.95M | 6.22 | -10.38% | - |
212 | PTGX | Protagonist Therapeutics, Inc. | 418.93M | 8.61 | 0.23% | 46.89M |
213 | NUVL | Nuvalent, Inc. | 417.92M | 8.65 | 16.89% | - |
214 | ESPR | Esperion Therapeutics, Inc. | 410.80M | 6.52 | 10.70% | 89.31M |
215 | VRDN | Viridian Therapeutics, Inc. | 403.27M | 14.44 | 8.57% | 1.73M |
216 | CALT | Calliditas Therapeutics AB | 402.78M | 15.15 | 4.41% | 25.48M |
217 | GLUE | Monte Rosa Therapeutics, Inc. | 400.88M | 8.59 | 12.58% | - |
218 | KZR | Kezar Life Sciences, Inc. | 400.56M | 6.63 | 10.13% | - |
219 | IMTX | Immatics N.V. | 399.59M | 6.35 | -0.16% | 34.76M |
220 | ALXO | ALX Oncology Holdings, Inc. | 396.64M | 9.75 | 1.78% | - |
221 | ADMA | ADMA Biologics Inc. | 396.63M | 2.02 | 8.02% | 94.00M |
222 | HRTX | Heron Therapeutics, Inc. | 388.40M | 3.79 | 7.06% | 89.79M |
223 | BTAI | BioXcel Therapeutics, Inc. | 384.52M | 13.74 | 14.21% | - |
224 | RIGL | Rigel Pharmaceuticals, Inc. | 380.23M | 2.21 | 7.81% | 84.95M |
225 | RPTX | Repare Therapeutics, Inc. | 379.56M | 9.06 | 5.47% | 7.84M |
226 | MGTX | MeiraGTx Holdings PLC | 378.25M | 8.46 | -0.24% | - |
227 | IVA | Inventiva SA | 372.36M | 9.11 | 2.94% | 8.50M |
228 | RLYB | Rallybio Corporation | 371.76M | 11.57 | 6.15% | - |
229 | TALS | Talaris Therapeutics, Inc. | 368.60M | 8.89 | 35.93% | - |
230 | EWTX | Edgewise Therapeutics, Inc. | 365.87M | 7.38 | 1.24% | - |
231 | OTLK | Outlook Therapeutics, Inc. | 365.57M | 1.63 | 1.88% | - |
232 | ABUS | Arbutus Biopharma Corporation | 358.43M | 2.41 | 6.64% | 21.46M |
233 | GLS | Gelesis Holdings, Inc. | 358.33M | 4.95 | -1.00% | 18.70M |
234 | TARS | Tarsus Pharmaceuticals, Inc. | 355.42M | 13.50 | 3.53% | 24.13M |
235 | ABSI | Absci Corporation | 349.12M | 3.76 | 3.30% | 4.54M |
236 | TYRA | Tyra Biosciences, Inc. | 347.45M | 8.32 | 8.33% | - |
237 | TIG | Trean Insurance Group, Inc. | 344.01M | 6.72 | 5.50% | 238.52M |
238 | ZYME | Zymeworks Inc. | 339.69M | 5.88 | 10.11% | 27.95M |
239 | FMTX | Forma Therapeutics Holdings, Inc. | 339.09M | 6.74 | 4.50% | - |
240 | ICVX | Icosavax, Inc. | 338.90M | 8.53 | 15.12% | 7.80M |
241 | ENOB | Enochian Biosciences, Inc. | 336.23M | 6.35 | 5.66% | - |
242 | ADGI | Adagio Therapeutics, Inc. | 335.73M | 3.06 | 6.62% | - |
243 | ATHA | Athira Pharma, Inc. | 335.71M | 8.92 | 2.88% | - |
244 | CCCC | C4 Therapeutics, Inc. | 335.24M | 6.87 | 2.39% | 46.01M |
245 | MCRB | Seres Therapeutics, Inc. | 333.87M | 3.62 | 1.40% | 140.70M |
246 | AKRO | Akero Therapeutics, Inc. | 329.22M | 9.40 | 1.08% | - |
247 | GBIO | Generation Bio Co. | 328.83M | 5.76 | 0.88% | - |
248 | ANIK | Anika Therapeutics, Inc. | 327.96M | 22.55 | 2.18% | 150.20M |
249 | MNMD | Mind Medicine (MindMed), Inc. | 327.11M | 0.77 | -3.27% | - |
250 | MRSN | Mersana Therapeutics, Inc. | 326.86M | 3.37 | 8.01% | 2.07M |
251 | BLTE | Belite Bio, Inc | 322.88M | 13.40 | -2.90% | - |
252 | KOD | Kodiak Sciences Inc. | 317.44M | 6.11 | 7.19% | - |
253 | AADI | Aadi Bioscience, Inc. | 315.18M | 15.05 | 9.69% | 3.31M |
254 | THRX | Theseus Pharmaceuticals, Inc. | 310.40M | 8.02 | 7.94% | - |
255 | OPT | Opthea Limited | 307.82M | 6.89 | 5.82% | -110.33K |
256 | EIGR | Eiger BioPharmaceuticals, Inc. | 302.94M | 7.01 | -1.13% | 11.17M |
257 | ALVR | AlloVir, Inc. | 300.92M | 4.60 | 5.99% | - |
258 | LIAN | LianBio | 299.30M | 2.79 | 4.49% | - |
259 | AVTE | Aerovate Therapeutics, Inc. | 299.03M | 12.25 | 5.60% | - |
260 | TNYA | Tenaya Therapeutics, Inc. | 298.68M | 7.23 | 3.29% | - |
261 | RDUS | Radius Health, Inc. | 280.19M | 5.89 | 4.25% | 216.87M |
262 | VBIV | VBI Vaccines, Inc. | 276.34M | 1.07 | 2.89% | 456.00K |
263 | ACLX | Arcellx, Inc. | 268.38M | 7.51 | -1.31% | - |
264 | PGEN | Precigen, Inc. | 265.85M | 1.28 | - | 111.38M |
265 | PTE | PolarityTE, Inc. | 265.81M | 2.97 | 1,640.91% | 5.44M |
266 | MGNX | MacroGenics, Inc. | 264.35M | 4.31 | 4.36% | 71.67M |
267 | FDMT | 4D Molecular Therapeutics, Inc. | 261.63M | 8.10 | -4.26% | 17.26M |
268 | LXRX | Lexicon Pharmaceuticals, Inc. | 260.29M | 1.74 | 0.58% | 308.00K |
269 | AUTL | Autolus Therapeutics PLC | 260.00M | 2.86 | 5.15% | 2.23M |
270 | NVCT | Nuvectis Pharma, Inc. | 259.95M | 20.44 | 7.58% | - |
271 | ACIU | AC Immune SA | 258.78M | 3.10 | 3.68% | - |
272 | BLUE | Bluebird Bio, Inc. | 258.66M | 3.62 | 6.79% | -7.19M |
273 | CYDY | CytoDyn, Inc. | 258.60M | 0.36 | 7.46% | 266.00K |
274 | JNCE | Jounce Therapeutics, Inc. | 256.30M | 4.96 | 8.06% | 25.37M |
275 | EPIX | ESSA Pharma Inc. | 255.55M | 5.80 | -1.53% | - |
276 | ADAP | Adaptimmune Therapeutics PLC | 254.13M | 1.57 | 10.56% | 9.29M |
277 | VYGR | Voyager Therapeutics, Inc. | 252.27M | 6.56 | 0.46% | 31.57M |
278 | CMPX | Compass Therapeutics, Inc. | 248.15M | 2.45 | -8.24% | - |
279 | VTGN | VistaGen Therapeutics, Inc. | 247.83M | 1.20 | 0.84% | 1.51M |
280 | PEPG | PepGen Inc. | 244.92M | 11.91 | 5.77% | - |
281 | IPHA | Innate Pharma S.A. | 244.84M | 3.07 | 2.44% | 28.07M |
282 | GRCL | Gracell Biotechnologies, Inc. | 243.09M | 3.51 | 2.33% | 57.19K |
283 | ALPN | Alpine Immune Sciences, Inc. | 242.63M | 8.00 | 1.39% | 33.87M |
284 | KRON | Kronos Bio, Inc. | 240.77M | 3.94 | 8.54% | - |
285 | STRO | Sutro Biopharma, Inc. | 239.36M | 5.10 | 7.60% | 53.12M |
286 | IMMP | Immutep Limited | 237.02M | 2.66 | 9.47% | 3.26M |
287 | PRLD | Prelude Therapeutics, Inc. | 232.28M | 4.87 | 2.96% | - |
288 | CMPI | Checkmate Pharmaceuticals, Inc. | 230.74M | 10.47 | 0.10% | - |
289 | ALT | Altimmune, Inc. | 228.65M | 5.29 | 9.98% | 3.60M |
290 | THTX | Theratechnologies Inc. | 228.29M | 2.40 | -2.83% | 56.99M |
291 | KALV | KalVista Pharmaceuticals, Inc. | 227.76M | 9.28 | 1.31% | - |
292 | KMDA | Kamada Ltd. | 222.40M | 4.93 | 3.79% | 103.64M |
293 | DMTK | DermTech, Inc. | 218.57M | 7.30 | -0.95% | 13.03M |
294 | VSTM | Verastem, Inc. | 218.04M | 1.17 | 13.59% | 3.64M |
295 | MOLN | Molecular Partners AG | 216.58M | 6.70 | 4.20% | 197.35M |
296 | VECT | VectivBio Holding AG | 216.56M | 6.02 | 6.08% | - |
297 | SRRK | Scholar Rock Holding Corporation | 211.45M | 5.99 | 14.97% | 47.30M |
298 | LCTX | Lineage Cell Therapeutics, Inc. | 205.37M | 1.21 | 5.22% | 9.19M |
299 | XOMA | XOMA Corporation | 202.95M | 17.77 | 2.96% | 40.89M |
300 | IMUX | Immunic, Inc. | 198.82M | 6.51 | 7.60% | - |
301 | GTHX | G1 Therapeutics, Inc. | 197.73M | 4.63 | 8.69% | 24.16M |
302 | TRDA | Entrada Therapeutics, Inc. | 192.58M | 6.14 | 5.68% | - |
303 | LGVN | Longeveron, Inc. | 190.71M | 9.12 | 14.86% | 1.30M |
304 | NBTX | Nanobiotix S.A. | 190.31M | 5.46 | 1.30% | 3.01M |
305 | COGT | Cogent Biosciences, Inc. | 189.69M | 4.14 | 3.76% | - |
306 | ATHX | Athersys, Inc. | 186.40M | 0.72 | 11.45% | 8.43M |
307 | VKTX | Viking Therapeutics, Inc. | 185.70M | 2.40 | 2.56% | - |
308 | XBIT | XBiotech Inc. | 181.42M | 5.96 | 6.81% | 14.04M |
309 | ALLK | Allakos Inc. | 179.67M | 3.28 | 2.82% | - |
310 | IOBT | IO Biotech, Inc. | 178.08M | 6.18 | -10.17% | - |
311 | PLRX | Pliant Therapeutics, Inc. | 177.95M | 4.92 | 4.68% | 6.65M |
312 | FUSN | Fusion Pharmaceuticals, Inc. | 172.50M | 3.98 | 3.65% | 2.03M |
313 | LYRA | Lyra Therapeutics, Inc. | 168.99M | 5.31 | 4.73% | 5.65M |
314 | VACC | Vaccitech plc | 168.89M | 4.54 | 1.79% | 15.07M |
315 | GNFT | Genfit S.A. | 168.38M | 3.38 | -0.88% | 97.25M |
316 | RYTM | Rhythm Pharmaceuticals, Inc. | 168.31M | 3.34 | 3.73% | 4.62M |
317 | IKNA | Ikena Oncology, Inc. | 166.94M | 4.01 | 9.86% | 30.90M |
318 | INZY | Inozyme Pharma, Inc. | 166.80M | 4.16 | 5.05% | - |
319 | AMTI | Applied Molecular Transport, Inc. | 165.05M | 4.27 | 7.02% | - |
320 | VOR | Vor Biopharma, Inc. | 161.30M | 4.29 | 6.98% | - |
321 | IMPL | Impel NeuroPharma, Inc. | 160.13M | 6.91 | 1.92% | 668.00K |
322 | CNCE | Concert Pharmaceuticals, Inc. | 159.49M | 4.39 | 7.60% | 32.57M |
323 | GRPH | Graphite Bio, Inc. | 159.23M | 2.62 | 5.65% | - |
324 | CLLS | Cellectis S.A. | 158.31M | 3.48 | 10.83% | 42.94M |
325 | GRTS | Gritstone bio, Inc. | 155.82M | 2.14 | 2.39% | 15.71M |
326 | SVRA | Savara, Inc. | 155.10M | 1.36 | 3.03% | - |
327 | FENC | Fennec Pharmaceuticals Inc. | 154.93M | 5.95 | - | - |
328 | BMEA | Biomea Fusion, Inc. | 154.59M | 5.22 | 34.54% | - |
329 | AMAM | Ambrx Biopharma, Inc. | 154.35M | 4.00 | -0.01% | 7.46M |
330 | ARMP | Armata Pharmaceuticals, Inc. | 154.20M | 4.27 | 1.67% | 4.64M |
331 | ALDX | Aldeyra Therapeutics, Inc. | 153.92M | 2.64 | 5.60% | - |
332 | CMRX | Chimerix, Inc. | 153.01M | 1.75 | 5.42% | 559.00K |
333 | ORIC | Oric Pharmaceuticals Inc. | 152.78M | 3.87 | 10.57% | - |
334 | PDSB | PDS Biotechnology Corporation | 152.21M | 5.35 | 3.88% | - |
335 | OVID | Ovid Therapeutics Inc. | 152.10M | 2.16 | 1.89% | 1.45M |
336 | OMGA | Omega Therapeutics, Inc. | 151.68M | 3.17 | 17.84% | 144.00K |
337 | ABOS | Acumen Pharmaceuticals, Inc. | 147.81M | 3.65 | 13.00% | - |
338 | MTNB | Matinas BioPharma Holdings, Inc. | 147.32M | 0.67 | 1.30% | - |
339 | AVEO | AVEO Pharmaceuticals, Inc. | 146.53M | 4.25 | 5.72% | 61.30M |
340 | GMDA | Gamida Cell Ltd. | 144.47M | 2.41 | 2.12% | - |
341 | DBVT | DBV Technologies S.A. | 142.15M | 1.29 | 5.74% | 5.31M |
342 | CVM | Cel-Sci Corporation | 141.64M | 3.27 | 11.99% | - |
343 | RCEL | AVITA Medical, Inc. | 141.00M | 5.65 | 1.99% | 33.55M |
344 | SPPI | Spectrum Pharmaceuticals, Inc. | 140.09M | 0.78 | -0.27% | - |
345 | PSTX | Poseida Therapeutics, Inc. | 139.83M | 2.23 | 2.29% | 32.67M |
346 | CLNN | Clene, Inc. | 139.80M | 2.21 | 3.27% | 540.00K |
347 | OCX | OncoCyte Corporation | 138.66M | 1.17 | 0.86% | 8.03M |
348 | ATNM | Actinium Pharmaceuticals, Inc. | 137.29M | 6.20 | 8.01% | 1.46M |
349 | STTK | Shattuck Labs, Inc. | 136.89M | 3.23 | 0.62% | 27.75M |
350 | OBSV | ObsEva SA | 135.52M | 1.65 | 5.77% | - |
351 | PIRS | Pieris Pharmaceuticals, Inc. | 134.86M | 1.82 | 7.69% | 26.77M |
352 | INMB | Inmune Bio Inc. | 134.42M | 7.49 | 4.61% | 340.00K |
353 | HOWL | Werewolf Therapeutics, Inc. | 134.40M | 4.86 | 6.81% | - |
354 | TSHA | Taysha Gene Therapies, Inc. | 133.56M | 3.30 | -0.60% | - |
355 | IMRX | Immuneering Corporation | 133.51M | 5.06 | 7.89% | 1.52M |
356 | URGN | UroGen Pharma Ltd. | 133.44M | 5.88 | 5.19% | 54.12M |
357 | HGEN | Humanigen Inc. | 132.79M | 1.88 | 5.62% | 4.15M |
358 | CUE | Cue Biopharma, Inc. | 132.65M | 3.75 | 3.59% | 14.39M |
359 | ANNX | Annexon, Inc. | 132.27M | 3.43 | 3.94% | - |
360 | CFRX | ContraFect Corporation | 131.76M | 3.35 | 4.69% | - |
361 | CKPT | Checkpoint Therapeutics, Inc. | 131.08M | 1.44 | 15.20% | 252.00K |
362 | ADAG | Adagene, Inc. | 130.29M | 2.98 | -4.65% | 10.18M |
363 | SELB | Selecta Biosciences, Inc. | 127.73M | 0.84 | 9.23% | 108.03M |
364 | NYMX | Nymox Pharmaceutical Corporation | 124.59M | 1.38 | 2.22% | - |
365 | OYST | Oyster Point Pharma, Inc. | 124.55M | 4.67 | -2.71% | 27.24M |
366 | GLSI | Greenwich LifeSciences, Inc. | 123.17M | 9.51 | -0.73% | - |
367 | CTMX | CytomX Therapeutics, Inc. | 121.64M | 1.86 | 7.51% | 70.74M |
368 | MNOV | MediciNova, Inc. | 119.18M | 2.43 | 1.25% | 37.50K |
369 | RVLP | RVL Pharmaceuticals plc | 118.64M | 1.42 | 0.71% | 38.01M |
370 | DTIL | Precision BioSciences, Inc. | 117.51M | 1.89 | 6.78% | 102.50M |
371 | LPTX | Leap Therapeutics, Inc. | 116.58M | 1.32 | 0.76% | 1.13M |
372 | IPA | ImmunoPrecise Antibodies Ltd. | 115.11M | 4.89 | 1.24% | 15.20M |
373 | CADL | Candel Therapeutics, Inc. | 114.77M | 4.00 | 3.63% | - |
374 | JSPR | Jasper Therapeutics, Inc. | 114.39M | 3.00 | 1.01% | - |
375 | SBTX | Silverback Therapeutics, Inc. | 113.87M | 3.24 | 6.93% | - |
376 | SURF | Surface Oncology, Inc. | 113.59M | 2.08 | 10.64% | 31.06M |
377 | AKUS | Akouos, Inc. | 113.23M | 3.27 | 3.48% | - |
378 | GNTA | Genenta Science S.p.A. | 112.94M | 6.20 | 9.35% | - |
379 | FNCH | Finch Therapeutics Group, Inc. | 112.72M | 2.37 | 10.75% | 15.33M |
380 | RZLT | Rezolute, Inc. | 112.50M | 3.35 | -5.10% | - |
381 | CLVS | Clovis Oncology, Inc. | 112.43M | 0.78 | -5.77% | 144.95M |
382 | TCRT | Alaunos Therapeutics, Inc. | 112.23M | 0.52 | 3.82% | 398.00K |
383 | HRBR | Harbor Diversified Inc. | 111.40M | 2.37 | -2.57% | 264.78M |
384 | LJPC | La Jolla Pharmaceutical Company | 107.87M | 4.21 | 1.20% | 75.72M |
385 | BCLI | Brainstorm Cell Therapeutics Inc. | 107.63M | 2.95 | 3.51% | - |
386 | VBLT | Vascular Biogenics Ltd. | 106.78M | 1.54 | 5.48% | 768.00K |
387 | APTO | Aptose Biosciences, Inc. | 106.06M | 1.15 | 4.55% | - |
388 | NXTC | NextCure, Inc. | 104.88M | 3.78 | 8.62% | - |
389 | RUBY | Rubius Therapeutics, Inc. | 104.65M | 1.16 | -3.33% | - |
390 | SMMT | Summit Therapeutics Inc. | 104.01M | 1.06 | 0.95% | 1.87M |
391 | ELYM | Eliem Therapeutics, Inc. | 103.88M | 3.91 | 16.02% | - |
392 | ANIX | Anixa Biosciences, Inc. | 102.22M | 3.39 | -1.74% | - |
393 | PASG | Passage Bio, Inc. | 101.56M | 1.87 | 10.65% | - |
394 | CLGN | CollPlant Biotechnologies Ltd. | 100.65M | 9.14 | 6.78% | 15.64M |
395 | ARDX | Ardelyx, Inc. | 100.35M | 0.69 | 7.41% | 3.98M |
396 | PYPD | PolyPid Ltd. | 99.11M | 5.09 | 6.49% | - |
397 | CRTX | Cortexyme, Inc. | 98.29M | 3.26 | -3.84% | - |
398 | AQB | AquaBounty Technologies, Inc. | 97.42M | 1.37 | 4.58% | 2.06M |
399 | FBIO | Fortress Biotech, Inc. | 97.37M | 0.91 | 5.49% | 81.13M |
400 | ACHL | Achilles Therapeutics plc | 95.77M | 2.35 | 2.17% | - |
401 | EVLO | Evelo Biosciences, Inc. | 94.98M | 1.77 | 9.94% | - |
402 | AGLE | Aeglea Biotherapeutics, Inc. | 94.21M | 1.54 | 7.69% | 20.10M |
403 | HARP | Harpoon Therapeutics, Inc. | 93.96M | 2.84 | 20.34% | 20.55M |
404 | EPZM | Epizyme, Inc. | 92.81M | 0.56 | 12.15% | 38.49M |
405 | TCRR | TCR2 Therapeutics Inc. | 92.51M | 2.40 | 2.13% | - |
406 | ALZN | Alzamend Neuro, Inc. | 92.08M | 0.99 | 7.25% | - |
407 | LVTX | LAVA Therapeutics N.V. | 92.02M | 3.57 | -6.30% | 5.68M |
408 | NRXP | NRx Pharmaceuticals, Inc. | 90.63M | 1.36 | - | - |
409 | PTN | Palatin Technologies, Inc. | 90.36M | 0.39 | 0.03% | 745.56K |
410 | SQZ | SQZ Biotechnologies Company | 90.36M | 3.21 | 5.94% | 24.51M |
411 | MYMD | MyMD Pharmaceuticals, Inc. | 90.20M | 2.37 | 1.28% | - |
412 | PBYI | Puma Biotechnology Inc. | 89.95M | 2.00 | 6.38% | 200.72M |
413 | LIFE | aTyr Pharma, Inc. | 89.78M | 3.20 | 3.90% | - |
414 | BCAB | BioAtla, Inc. | 89.42M | 2.39 | 3.91% | 250.00K |
415 | SESN | Sesen Bio, Inc. | 89.40M | 0.45 | 8.26% | 22.23M |
416 | VIGL | Vigil Neuroscience, Inc. | 89.32M | 3.16 | 10.88% | - |
417 | OLMA | Olema Pharmaceuticals, Inc. | 88.78M | 2.20 | - | - |
418 | SRZN | Surrozen, Inc. | 86.76M | 2.47 | 6.47% | - |
419 | FIXX | Homology Medicines, Inc. | 86.65M | 1.51 | 4.86% | 33.97M |
420 | OTLC | Oncotelic Therapeutics, Inc. | 85.95M | 0.23 | 8.10% | - |
421 | SABS | SAB Biotherapeutics Inc. | 85.92M | 2.00 | 3.09% | - |
422 | HOOK | HOOKIPA Pharma Inc. | 85.87M | 1.57 | 12.14% | 14.59M |
423 | PRTG | Portage Biotech, Inc. | 85.81M | 6.43 | 6.63% | - |
424 | EQ | Equillium, Inc. | 85.00M | 2.48 | 10.71% | - |
425 | CNTG | Centogene N.V. | 84.73M | 3.13 | -7.18% | 215.82M |
426 | ETTX | Entasis Therapeutics Holdings Inc. | 84.70M | 1.77 | 1.14% | - |
427 | IMV | IMV Inc. | 83.87M | 1.02 | 5.56% | 112.70K |
428 | ASMB | Assembly Biosciences, Inc. | 82.45M | 1.71 | 6.21% | 6.25M |
429 | CELC | Celcuity Inc. | 82.06M | 5.50 | -2.83% | - |
430 | ADVM | Adverum Biotechnologies, Inc. | 81.81M | 0.83 | 2.30% | - |
431 | GTBP | GT Biopharma, Inc | 81.72M | 2.47 | 19.90% | - |
432 | SYBX | Synlogic, Inc. | 81.49M | 1.16 | 6.42% | 2.00M |
433 | MIRO | Miromatrix Medical, Inc. | 81.24M | 3.95 | 2.07% | 33.73K |
434 | AXLA | Axcella Health, Inc. | 80.97M | 1.54 | 6.21% | - |
435 | CYBN | Cybin, Inc. | 80.52M | 0.49 | 14.15% | - |
436 | XLO | Xilio Therapeutics, Inc. | 80.49M | 2.93 | -5.18% | - |
437 | GALT | Galectin Therapeutics Inc. | 80.13M | 1.35 | 7.14% | - |
438 | LBPH | Longboard Pharmaceuticals, Inc. | 79.88M | 4.64 | 3.11% | - |
439 | ANVS | Annovis Bio, Inc. | 79.76M | 9.77 | 3.72% | - |
440 | CRIS | Curis, Inc. | 79.14M | 0.86 | 0.38% | 10.52M |
441 | MBIO | Mustang Bio, Inc. | 78.73M | 0.76 | 4.22% | - |
442 | VIRX | Viracta Therapeutics, Inc. | 78.73M | 2.10 | -1.41% | - |
443 | BCTX | BriaCell Therapeutics Corp. | 77.47M | 5.07 | 13.42% | - |
444 | TCRX | TScan Therapeutics, Inc. | 76.90M | 3.20 | 15.94% | 11.14M |
445 | CAPR | Capricor Therapeutics, Inc. | 76.62M | 3.15 | 1.94% | 204.08K |
446 | ELEV | Elevation Oncology, Inc. | 76.04M | 3.27 | -10.17% | - |
447 | KZIA | Kazia Therapeutics Limited | 75.92M | 5.67 | 8.41% | 10.89M |
448 | LBPS | 4D pharma PLC | 75.73M | 3.36 | 7.35% | 718.00K |
449 | HCWB | HCW Biologics, Inc. | 75.53M | 2.11 | - | - |
450 | RAIN | Rain Therapeutics, Inc. | 75.08M | 2.83 | 23.04% | - |
451 | GNPX | Genprex, Inc. | 74.70M | 1.56 | 3.31% | - |
452 | BCEL | Atreca, Inc. | 73.32M | 1.90 | 13.10% | - |
453 | EFTR | eFFECTOR Therapeutics, Inc. | 73.15M | 1.78 | -0.45% | 1.43M |
454 | ANEB | Anebulo Pharmaceuticals, Inc. | 72.84M | 3.12 | - | - |
455 | BIVI | BioVie, Inc. | 71.95M | 2.88 | 0.70% | - |
456 | PYXS | Pyxis Oncology, Inc. | 71.54M | 2.18 | 7.92% | - |
457 | BDTX | Black Diamond Therapeutics, Inc. | 71.49M | 1.97 | 5.91% | - |
458 | MGTA | Magenta Therapeutics, Inc. | 69.38M | 1.18 | 7.27% | - |
459 | IFRX | InflaRx N.V. | 68.72M | 1.48 | 6.48% | - |
460 | MACK | Merrimack Pharmaceuticals, Inc. | 68.53M | 5.11 | - | - |
461 | CGTX | Cognition Therapeutics, Inc. | 67.79M | 2.89 | 1.05% | - |
462 | AKBA | Akebia Therapeutics, Inc. | 67.72M | 0.37 | -2.90% | 222.97M |
463 | ENTX | Entera Bio Ltd. | 67.11M | 2.33 | -1.27% | 482.00K |
464 | ONCY | Oncolytics Biotech Inc. | 66.96M | 1.15 | 1.33% | - |
465 | CYT | Cyteir Therapeutics, Inc. | 66.92M | 1.89 | 0.53% | - |
466 | MEIP | MEI Pharma, Inc. | 66.25M | 0.50 | 3.71% | 44.14M |
467 | ACHV | Achieve Life Sciences, Inc. | 66.13M | 6.83 | 0.59% | - |
468 | BOLT | Bolt Biotherapeutics, Inc. | 65.95M | 1.76 | 13.55% | 1.26M |
469 | MTEM | Molecular Templates, Inc. | 65.92M | 1.17 | - | 43.96M |
470 | DYAI | Dyadic International, Inc. | 65.86M | 2.33 | 4.02% | 2.59M |
471 | DMAC | DiaMedica Therapeutics Inc. | 65.58M | 2.48 | 3.77% | - |
472 | LUMO | Lumos Pharma, Inc. | 64.90M | 7.76 | 4.37% | 341.00K |
473 | BLRX | BioLineRx Ltd. | 64.71M | 1.32 | 13.79% | - |
474 | ABVC | ABVC BioPharma, Inc. | 64.55M | 2.13 | 0.47% | 355.80K |
475 | ICCC | ImmuCell Corporation | 64.42M | 8.32 | -0.36% | 21.14M |
476 | LTRN | Lantern Pharma, Inc. | 63.58M | 5.87 | 1.38% | - |
477 | SLDB | Solid Biosciences Inc. | 63.56M | 0.56 | 4.06% | 12.21M |
478 | DBTX | Decibel Therapeutics, Inc. | 62.91M | 2.52 | 16.13% | - |
479 | CDAK | Codiak BioSciences, Inc. | 62.76M | 2.79 | 5.28% | 22.45M |
480 | MDNA | Medicenna Therapeutics Corp. | 62.14M | 1.10 | 1.85% | - |
481 | BWV | Blue Water Vaccines, Inc. | 61.92M | 4.83 | 17.81% | - |
482 | SLS | SELLAS Life Sciences Group, Inc. | 61.20M | 2.98 | 5.30% | 2.90M |
483 | CRDF | Cardiff Oncology, Inc. | 60.63M | 1.40 | 6.06% | 361.00K |
484 | GMTX | Gemini Therapeutics, Inc. | 60.52M | 1.40 | 5.26% | - |
485 | ORTX | Orchard Therapeutics PLC | 60.43M | 0.48 | 2.50% | 7.20M |
486 | INFI | Infinity Pharmaceuticals, Inc. | 60.43M | 0.68 | 21.34% | 2.04M |
487 | UBX | Unity Biotechnology, Inc. | 58.79M | 0.85 | 7.08% | - |
488 | ODTC | Odonate Therapeutics, Inc. | 58.51M | 1.52 | 0.66% | - |
489 | ETNB | 89bio, Inc. | 58.41M | 2.87 | 8.71% | - |
490 | BNOX | Bionomics Limited | 57.34M | 7.56 | - | - |
491 | ATNX | Athenex, Inc. | 55.98M | 0.50 | 6.29% | 108.88M |
492 | CABA | Cabaletta Bio, Inc. | 54.48M | 1.88 | 3.87% | - |
493 | IBIO | iBio, Inc. | 54.32M | 0.25 | 2.81% | 2.81M |
494 | SPRO | Spero Therapeutics, Inc. | 54.05M | 1.65 | -3.51% | 13.03M |
495 | ATXS | Astria Therapeutics, Inc. | 53.89M | 4.14 | 2.99% | - |
496 | CASI | CASI Pharmaceuticals, Inc. | 53.06M | 0.39 | 7.65% | 33.49M |
497 | BFAGY | Biofrontera AG | 53.03M | 1.87 | -17.98% | - |
498 | RPHM | Reneo Pharmaceuticals, Inc. | 52.83M | 2.16 | 3.35% | - |
499 | ORGS | Orgenesis Inc. | 52.62M | 2.12 | -21.77% | 35.50M |
500 | YECO | EV Biologics, Inc. | 52.59M | 0.78 | 29.44% | - |
501 | INAB | IN8bio, Inc. | 52.56M | 2.79 | -11.43% | - |
502 | SNSE | Sensei Biotherapeutics, Inc. | 52.07M | 1.70 | 6.25% | - |
503 | PPBT | Purple Biotech Ltd. | 50.95M | 2.84 | -2.07% | - |
504 | FSTX | F-star Therapeutics, Inc. | 50.66M | 2.35 | 0.43% | 20.80M |
505 | MREO | Mereo BioPharma Group PLC | 50.30M | 0.43 | -1.53% | 48.62M |
506 | PLX | Protalix BioTherapeutics, Inc. | 49.61M | 1.07 | - | 43.12M |
507 | BSTG | Biostage, Inc. | 49.61M | 4.61 | -16.18% | 572.00 |
508 | BYSI | BeyondSpring, Inc. | 49.44M | 1.27 | 3.25% | 1.35M |
509 | CRVS | Corvus Pharmaceuticals, Inc. | 49.35M | 1.06 | 2.91% | - |
510 | ALGS | Aligos Therapeutics, Inc. | 49.10M | 1.15 | 5.51% | - |
511 | SYRS | Syros Pharmaceuticals, Inc. | 48.83M | 0.78 | 1.01% | 24.13M |
512 | FRLN | Freeline Therapeutics Holdings PLC | 48.67M | 0.79 | 6.67% | - |
513 | VCNX | Vaccinex, Inc. | 48.64M | 1.14 | -3.39% | 50.00K |
514 | PRQR | ProQR Therapeutics N.V. | 48.42M | 0.68 | 2.91% | 3.95M |
515 | BTX | Brooklyn ImmunoTherapeutics, Inc. | 48.24M | 0.84 | 4.45% | - |
516 | PMCB | PharmaCyte Biotech, Inc. | 47.45M | 2.29 | - | - |
517 | NLTX | Neoleukin Therapeutics, Inc. | 46.75M | 1.10 | 0.92% | - |
518 | NEXI | NexImmune, Inc. | 46.60M | 2.04 | -3.32% | - |
519 | FREQ | Frequency Therapeutics, Inc. | 46.52M | 1.33 | 1.53% | 9.42M |
520 | APTX | Aptinyx Inc. | 45.92M | 0.68 | 7.23% | - |
521 | PSTI | Pluristem Therapeutics, Inc. | 45.77M | 1.42 | 3.29% | 234.00K |
522 | CNTB | Connect Biopharma Holdings Limited | 45.71M | 0.83 | 2.89% | - |
523 | AIM | AIM ImmunoTech, Inc. | 45.35M | 0.95 | -4.07% | 135.00K |
524 | GRTX | Galera Therapeutics, Inc. | 45.33M | 1.69 | -1.17% | - |
525 | TRVN | Trevena, Inc. | 45.32M | 0.27 | -9.58% | 378.00K |
526 | APLT | Applied Therapeutics, Inc. | 44.60M | 1.70 | 2.41% | - |
527 | LRMR | Larimar Therapeutics, Inc. | 44.45M | 2.51 | -1.18% | - |
528 | PHAS | PhaseBio Pharmaceuticals, Inc. | 44.07M | 0.91 | -2.67% | - |
529 | TLSA | Tiziana Life Sciences Ltd | 43.79M | 0.90 | 5.04% | - |
530 | TYME | Tyme Technologies, Inc. | 43.53M | 0.25 | 1.12% | - |
531 | ISR | IsoRay, Inc. | 43.32M | 0.31 | 2.35% | 11.00M |
532 | INKT | MiNK Therapeutics, Inc. | 43.27M | 1.29 | 3.20% | - |
533 | VINC | Vincerx Pharma, Inc. | 42.96M | 2.04 | 1.49% | - |
534 | ATNF | 180 Life Sciences Corp. | 42.95M | 1.26 | -4.55% | - |
535 | OCUP | Ocuphire Pharma, Inc. | 42.80M | 2.21 | 2.32% | 589.00K |
536 | EVAX | Evaxion Biotech A/S | 42.69M | 1.84 | -3.16% | - |
537 | AGTC | Applied Genetic Technologies Corporation | 42.09M | 0.84 | 11.99% | 500.00K |
538 | ONCT | Oncternal Therapeutics, Inc. | 41.61M | 0.84 | 12.90% | 4.31M |
539 | ELDN | Eledon Pharmaceuticals, Inc. | 40.58M | 2.95 | 10.49% | - |
540 | APM | Aptorum Group Limited | 40.34M | 1.13 | 7.62% | 1.54M |
541 | TERN | Terns Pharmaceuticals, Inc. | 39.67M | 1.57 | 4.67% | 1.00M |
542 | CYAD | Celyad Oncology SA | 39.02M | 1.65 | 6.45% | - |
543 | FWP | Forward Pharma A/S | 39.00M | 5.50 | -4.51% | - |
544 | TTOO | T2 Biosystems, Inc. | 38.60M | 0.23 | 5.15% | 28.34M |
545 | TCON | TRACON Pharmaceuticals, Inc. | 38.55M | 1.92 | -0.52% | 346.00K |
546 | ALRN | Aileron Therapeutics, Inc. | 38.14M | 0.42 | 11.82% | - |
547 | MBRX | Moleculin Biotech, Inc. | 38.01M | 1.33 | 5.56% | - |
548 | VIRI | Virios Therapeutics, Inc. | 37.90M | 4.55 | 17.57% | - |
549 | EVGN | Evogene Ltd. | 37.57M | 0.91 | 3.65% | 930.00K |
550 | BTTX | Better Therapeutics, Inc. | 37.53M | 1.59 | 2.58% | - |
551 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 37.10M | 0.30 | -0.54% | 233.88K |
552 | ANGN | Angion Biomedica Corp. | 36.55M | 1.22 | -6.15% | 29.59M |
553 | SNPX | Synaptogenix, Inc. | 36.50M | 5.36 | 10.97% | - |
554 | SYN | Synthetic Biologics, Inc. | 36.44M | 0.23 | -0.17% | - |
555 | GLTO | Galecto, Inc. | 36.13M | 1.40 | 0.72% | - |
556 | TARA | Protara Therapeutics, Inc. | 35.89M | 3.19 | 2.24% | - |
557 | AVRO | Avrobio, Inc. | 35.87M | 0.82 | 4.65% | - |
558 | XFOR | X4 Pharmaceuticals, Inc. | 35.45M | 1.15 | -7.26% | - |
559 | RCOR | Renovacor, Inc. | 35.23M | 2.04 | -12.07% | - |
560 | ERYP | Erytech Pharma S.A. | 34.74M | 1.12 | - | 4.75M |
561 | SPRB | Spruce Biosciences, Inc. | 34.53M | 1.47 | 9.70% | - |
562 | AVTX | Avalo Therapeutics, Inc. | 34.42M | 0.31 | 15.08% | 6.10M |
563 | INTI | Inhibitor Therapeutics, Inc. | 34.37M | 0.09 | - | - |
564 | CMMB | Chemomab Therapeutics Ltd. | 34.04M | 2.99 | -1.36% | - |
565 | NBSE | NeuBase Therapeutics, Inc. | 33.75M | 1.03 | 7.29% | - |
566 | ABIO | ARCA biopharma, Inc. | 33.72M | 2.34 | 2.18% | - |
567 | ONCR | Oncorus, Inc. | 33.39M | 1.29 | 7.50% | - |
568 | IMNM | Immunome, Inc. | 33.35M | 2.75 | 12.25% | - |
569 | CDTX | Cidara Therapeutics, Inc. | 33.34M | 0.48 | 8.15% | 54.27M |
570 | IMRA | IMARA Inc. | 33.24M | 1.27 | 6.30% | - |
571 | GLYC | GlycoMimetics, Inc. | 32.71M | 0.62 | 3.86% | 104.33K |
572 | TPST | Tempest Therapeutics, Inc. | 32.41M | 3.14 | 4.32% | - |
573 | ASLN | ASLAN Pharmaceuticals Limited | 32.19M | 0.46 | -0.32% | - |
574 | GANX | Gain Therapeutics, Inc. | 31.97M | 2.69 | - | 204.73K |
575 | NCNA | NuCana PLC | 31.75M | 0.61 | 2.29% | - |
576 | ARAV | Aravive, Inc. | 31.71M | 1.10 | -1.79% | 8.28M |
577 | ASNS | Actelis Networks, Inc. | 31.20M | 2.00 | 2.56% | 8.55M |
578 | OGEN | Oragenics Inc. | 31.07M | 0.27 | 2.65% | 102.07K |
579 | NTRB | Nutriband Inc. | 30.74M | 3.93 | -2.00% | 1.42M |
580 | EDSA | Edesa Biotech, Inc. | 30.15M | 1.95 | 5.98% | - |
581 | LABP | Landos Biopharma, Inc. | 29.99M | 0.75 | 15.79% | - |
582 | ATHE | Alterity Therapeutics Limited | 29.95M | 0.69 | 5.39% | - |
583 | PCSA | Processa Pharmaceuticals, Inc. | 29.94M | 1.89 | 12.50% | - |
584 | MRKR | Marker Therapeutics, Inc. | 29.58M | 0.34 | 8.10% | 2.21M |
585 | ACXP | Acurx Pharmaceuticals, Inc. | 29.56M | 2.88 | 6.67% | - |
586 | AYLA | Ayala Pharmaceuticals, Inc. | 29.51M | 2.10 | -0.71% | 2.99M |
587 | VTVT | vTv Therapeutics Inc. | 29.45M | 0.44 | 11.93% | 5.02M |
588 | RGLS | Regulus Therapeutics Inc. | 29.40M | 0.20 | 6.56% | - |
589 | AIKI | AIkido Pharma, Inc. | 29.24M | 0.33 | -0.76% | - |
590 | ONCS | OncoSec Medical Incorporated | 28.90M | 0.73 | 4.47% | - |
591 | CLBS | Caladrius Biosciences, Inc. | 27.84M | 0.46 | 2.68% | - |
592 | SGTX | Sigilon Therapeutics, Inc. | 27.83M | 0.86 | 12.73% | 9.81M |
593 | AGE | AgeX Therapeutics, Inc. | 27.79M | 0.72 | 4.43% | 93.00K |
594 | RNAZ | TransCode Therapeutics, Inc. | 27.64M | 2.13 | 2.90% | - |
595 | TCBP | TC BioPharm (Holdings) plc | 26.80M | 0.96 | 0.21% | 2.73M |
596 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 26.48M | 1.75 | 9.38% | - |
597 | CANF | Can-Fite BioPharma Ltd. | 26.05M | 0.91 | 5.67% | 853.00K |
598 | BIOC | Biocept, Inc. | 26.03M | 1.54 | -0.65% | 61.25M |
599 | ABEO | Abeona Therapeutics Inc. | 25.78M | 0.18 | -2.83% | 3.00M |
600 | NAVB | Navidea Biopharmaceuticals, Inc. | 24.85M | 0.82 | 5.40% | 407.78K |
601 | BCDA | BioCardia, Inc. | 24.77M | 1.42 | 2.90% | 1.03M |
602 | CYCN | Cyclerion Therapeutics, Inc. | 24.77M | 0.57 | 0.02% | 4.59M |
603 | MNPR | Monopar Therapeutics, Inc. | 24.48M | 1.94 | -1.52% | - |
604 | ADXN | Addex Therapeutics Ltd. | 24.34M | 3.80 | -7.99% | 2.51M |
605 | APVO | Aptevo Therapeutics Inc. | 24.24M | 4.84 | 4.54% | 12.99M |
606 | CLCS | Cell Source, Inc. | 24.10M | 0.70 | - | - |
607 | PHGE | BiomX, Inc. | 24.08M | 0.81 | 2.33% | - |
608 | AEZS | AEterna Zentaris Inc. | 23.73M | 0.19 | 0.95% | 6.19M |
609 | VYNE | VYNE Therapeutics, Inc. | 23.71M | 0.41 | 4.94% | 10.81M |
610 | ONVO | Organovo Holdings, Inc. | 23.59M | 2.71 | 5.86% | - |
611 | CLRB | Cellectar BioSciences, Inc. | 23.32M | 0.38 | -2.13% | - |
612 | SLNO | Soleno Therapeutics, Inc. | 22.85M | 0.19 | 7.64% | - |
613 | PBLA | Panbela Therapeutics, Inc. | 22.46M | 1.67 | 3.73% | - |
614 | BPTH | Bio-Path Holdings, Inc. | 22.27M | 3.11 | -2.51% | - |
615 | ENZN | Enzon Pharmaceuticals, Inc. | 22.24M | 0.30 | -0.03% | 320.00K |
616 | ARDS | Aridis Pharmaceuticals Inc. | 22.13M | 1.25 | 17.93% | 1.54M |
617 | KTTA | Pasithea Therapeutics Corp. | 21.94M | 0.96 | 9.15% | 15.06K |
618 | IDRA | Idera Pharmaceuticals, Inc. | 21.72M | 0.41 | 16.02% | - |
619 | SIOX | Sio Gene Therapies, Inc. | 21.51M | 0.29 | 1.85% | - |
620 | BBI | Brickell Biotech, Inc. | 21.49M | 0.18 | -4.00% | 479.00K |
621 | CALA | Calithera Biosciences, Inc. | 21.31M | 0.22 | 1.95% | 9.75M |
622 | BPTS | Biophytis S.A. | 21.10M | 1.43 | 8.33% | - |
623 | SKYE | Skye Bioscience, Inc. | 20.83M | 0.04 | 6.33% | - |
624 | INDP | Indaptus Therapeutics, Inc. | 20.32M | 2.45 | -0.81% | - |
625 | ENSC | Ensysce Biosciences, Inc. | 19.98M | 0.60 | -7.09% | - |
626 | SNGX | Soligenix, Inc. | 19.55M | 0.46 | 8.64% | 864.74K |
627 | VYNT | Vyant Bio, Inc. | 19.50M | 0.66 | -1.76% | 1.23M |
628 | GRAY | Graybug Vision, Inc. | 19.27M | 0.90 | 1.34% | - |
629 | MTCR | Metacrine, Inc. | 18.83M | 0.45 | 0.38% | - |
630 | LMNL | Liminal BioSciences Inc. | 18.63M | 0.60 | 1.71% | 343.65K |
631 | XRTX | XORTX Therapeutics Inc | 18.58M | 1.43 | -1.38% | - |
632 | QLGN | Qualigen Therapeutics, Inc. | 18.50M | 0.52 | -1.50% | 4.48M |
633 | IMMX | Immix Biopharma, Inc. | 18.47M | 1.33 | - | - |
634 | CLSN | Celsion Corporation | 18.46M | 2.60 | 1.56% | 500.00K |
635 | IMRN | Immuron Limited | 18.11M | 2.78 | 4.03% | 254.59K |
636 | IKT | Inhibikase Therapeutics, Inc. | 17.91M | 0.71 | 1.63% | 1.74M |
637 | FBRX | Forte Biosciences, Inc. | 17.86M | 1.21 | 12.56% | - |
638 | CWBR | CohBar, Inc. | 17.35M | 0.20 | 0.50% | - |
639 | OPGN | OpGen, Inc. | 17.22M | 0.37 | 11.96% | 3.95M |
640 | NNVC | NanoViricides, Inc. | 17.19M | 1.49 | 2.76% | - |
641 | WINT | Windtree Therapeutics, Inc. | 17.10M | 0.58 | -1.00% | - |
642 | TMBR | Timber Pharmaceuticals, Inc. | 16.54M | 0.26 | 1.80% | 928.98K |
643 | RNXT | RenovoRx, Inc. | 16.54M | 1.83 | 0.55% | - |
644 | NERV | Minerva Neurosciences, Inc. | 16.53M | 0.39 | -0.77% | - |
645 | DFFN | Diffusion Pharmaceuticals, Inc. | 16.35M | 8.02 | -1.35% | - |
646 | TENX | Tenax Therapeutics, Inc. | 15.88M | 0.63 | 10.29% | - |
647 | SONN | Sonnet BioTherapeutics Holdings, Inc. | 15.72M | 0.26 | 1.61% | 708.75K |
648 | GLMD | Galmed Pharmaceuticals Ltd. | 15.51M | 0.58 | 1.69% | - |
649 | VRPX | Virpax Pharmaceuticals, Inc. | 15.46M | 1.32 | 2.33% | - |
650 | XCUR | Exicure, Inc. | 15.44M | 0.13 | 9.21% | -483.00K |
651 | CELZ | Creative Medical Technology Holdings, Inc. | 15.21M | 1.60 | -5.33% | 87.75K |
652 | LIXT | Lixte Biotechnology Holdings, Inc. | 14.98M | 0.90 | 3.18% | - |
653 | APRE | Aprea Therapeutics, Inc. | 14.88M | 0.68 | -29.68% | - |
654 | MITO | Stealth BioTherapeutics Corp. | 14.70M | 0.25 | 0.78% | - |
655 | CYCC | Cyclacel Pharmaceuticals, Inc. | 14.69M | 1.47 | 3.52% | - |
656 | BLCM | Bellicum Pharmaceuticals, Inc. | 14.64M | 1.70 | 6.92% | 6.20M |
657 | NRBO | NeuroBo Pharmaceuticals, Inc. | 14.40M | 0.54 | -0.02% | - |
658 | CLXT | Calyxt, Inc. | 14.39M | 0.34 | 5.06% | 21.62M |
659 | IPIX | Innovation Pharmaceuticals Inc. | 14.12M | 0.03 | 11.15% | - |
660 | LOGC | LogicBio Therapeutics, Inc. | 14.01M | 0.43 | -1.21% | 7.77M |
661 | NRSN | NeuroSense Therapeutics Ltd. | 13.90M | 1.27 | -2.31% | - |
662 | GNCA | Genocea Biosciences, Inc. | 13.84M | 0.23 | 4.65% | 1.91M |
663 | CING | Cingulate, Inc. | 13.68M | 1.21 | 2.54% | - |
664 | BRTX | BioRestorative Therapies, Inc. | 13.27M | 3.66 | -5.67% | 46.00K |
665 | YTEN | Yield10 Bioscience, Inc. | 13.09M | 2.67 | -3.96% | 567.00K |
666 | STAB | Statera Biopharma, Inc. | 12.54M | 0.25 | 3.68% | 236.52K |
667 | CBIO | Catalyst Biosciences, Inc. | 12.43M | 0.40 | -1.08% | 6.67M |
668 | PTIX | Protagenic Therapeutics, Inc. | 12.32M | 0.71 | 2.75% | - |
669 | ALLR | Allarity Therapeutics, Inc. | 12.29M | 1.39 | 11.20% | - |
670 | NBIO | Nascent Biotech Inc. | 12.15M | 0.11 | 2.55% | 750.00K |
671 | DRUG | Bright Minds Biosciences Inc. | 12.07M | 1.02 | -4.67% | - |
672 | CYTO | Altamira Therapeutics Ltd. | 12.06M | 0.79 | 5.33% | 70.20K |
673 | YMTX | Yumanity Therapeutics, Inc. | 12.04M | 1.11 | 2.78% | 5.53M |
674 | LEXX | Lexaria Bioscience Corp. | 12.02M | 2.02 | -1.46% | 279.61K |
675 | UNCY | Unicycive Therapeutics, Inc. | 12.01M | 0.80 | 6.57% | - |
676 | INM | InMed Pharmaceuticals, Inc. | 11.92M | 0.83 | 3.76% | 574.68K |
677 | PSTV | Plus Therapeutics, Inc. | 11.75M | 0.53 | 3.76% | - |
678 | ADTX | Aditx, Inc. | 11.74M | 0.26 | -10.98% | 105.03K |
679 | ENVB | Enveric Biosciences, Inc. | 11.54M | 0.22 | 7.13% | - |
680 | MLCT | Malachite Innovations, Inc. | 11.32M | 0.22 | - | - |
681 | XTLB | XTL Biopharmaceuticals Ltd. | 11.24M | 1.86 | 13.42% | - |
682 | XBIO | Xenetic Biosciences, Inc. | 11.15M | 0.78 | 9.72% | 1.36M |
683 | ALNA | Allena Pharmaceuticals, Inc. | 11.04M | 0.12 | 9.33% | - |
684 | NLSP | NLS Pharmaceutics Ltd. | 10.61M | 0.60 | -5.00% | - |
685 | KTRA | Kintara Therapeutics, Inc. | 10.60M | 0.16 | -0.49% | - |
686 | HILS | Hillstream BioPharma, Inc. | 10.57M | 0.93 | - | - |
687 | SLRX | Salarius Pharmaceuticals, Inc. | 10.08M | 0.18 | 1.35% | 571.39K |
688 | MTP | Midatech Pharma PLC | 10.03M | 0.51 | -5.39% | 770.67K |
689 | ADXS | Advaxis, Inc. | 9.90M | 0.07 | 3.03% | 1.63M |
690 | REVB | Revelation Biosciences, Inc. | 9.85M | 0.65 | -3.97% | - |
691 | PALI | Palisade Bio, Inc. | 9.75M | 0.54 | -3.66% | - |
692 | QSAM | QSAM Biosciences, Inc. | 9.66M | 5.81 | 16.20% | - |
693 | HSTO | Histogen, Inc. | 9.66M | 0.19 | 21.34% | 4.36M |
694 | AXIM | AXIM Biotechnologies, Inc. | 9.62M | 0.06 | 2.10% | 116.11K |
695 | GBLX | GB Sciences, Inc. | 9.32M | 0.03 | -9.69% | - |
696 | SPRC | SciSparc Ltd. | 9.26M | 2.90 | 4.32% | - |
697 | PHIO | Phio Pharmaceuticals Corp. | 8.99M | 0.66 | -7.45% | - |
698 | ACOR | Acorda Therapeutics, Inc. | 8.76M | 0.66 | -3.06% | 122.74M |
699 | CPMV | Mosaic ImmunoEngineering, Inc. | 8.65M | 1.20 | 19.50% | - |
700 | SCPS | Scopus Biopharma, Inc. | 8.65M | 0.41 | 3.77% | - |
701 | BNTC | Benitec Biopharma Inc. | 8.58M | 1.05 | -2.78% | 75.00K |
702 | BXRX | Baudax Bio, Inc. | 7.58M | 1.18 | - | 1.30M |
703 | MHTX | Manhattan Scientifics, Inc. | 6.96M | 0.01 | - | 100.00K |
704 | DRMA | Dermata Therapeutics, Inc. | 6.55M | 0.71 | -4.57% | - |
705 | GOVX | GeoVax Labs, Inc. | 6.46M | 0.68 | 5.87% | 356.61K |
706 | HCYT | H-CYTE, Inc. | 6.12M | 0.02 | 1.05% | 1.61M |
707 | QNRX | Quoin Pharmaceuticals, Ltd. | 6.02M | 0.72 | 13.78% | - |
708 | FWBI | First Wave BioPharma, Inc. | 5.89M | 0.35 | 6.94% | - |
709 | CYTR | CytRx Corporation | 5.47M | 0.13 | 2.94% | - |
710 | KRBP | Kiromic BioPharma, Inc. | 5.34M | 0.34 | 1.86% | - |
711 | KPRX | Kiora Pharmaceuticals, Inc. | 5.24M | 0.41 | 7.53% | - |
712 | ANPC | AnPac Bio-Medical Science Co. Ltd. | 5.21M | 0.32 | 2.94% | - |
713 | VLON | Vallon Pharmaceuticals, Inc. | 4.02M | 0.59 | 6.20% | - |
714 | ISCO | International Stem Cell Corporation | 4.00M | 0.50 | - | 1.84M |
715 | USRM | U.S. Stem Cell, Inc. | 3.72M | 0.01 | -9.72% | 200.75K |
716 | QBIO | Q BioMed Inc. | 3.46M | 0.11 | -4.35% | 270.66K |
717 | NPTX | Neuropathix, Inc | 2.61M | 0.03 | 32.70% | 183.48K |
718 | BIEI | Premier Biomedical, Inc. | 1.60M | 0.00 | - | - |
719 | ATRX | Adhera Therapeutics, Inc. | 1.05M | 0.06 | -11.77% | - |
720 | PRED | Predictive Technology Group, Inc. | 988.67K | 0.00 | - | - |
721 | ANTH | Anthera Pharmaceuticals, Inc. | 617.83K | - | - | - |
722 | RBSH | Rebus Holdings, Inc. | 302.05K | 0.01 | 4.44% | - |
723 | GNBT | Generex Biotechnology Corp. | 225.05K | 0.00 | - | - |
724 | ADYX | Adynxx, Inc. | 580.00 | - | - | - |
725 | CRXM | Gene Biotherapeutics Inc. | 64.00 | - | - | - |